SeaStar Medical Holding Corporation
ICU
$4.14
$0.276.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 526.87% | 169.12% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 526.87% | 169.12% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 508.96% | 148.53% | -- | -- | -- |
| SG&A Expenses | -41.60% | -13.25% | -55.89% | -25.26% | 6.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.92% | -16.84% | -55.15% | 4.18% | 54.11% |
| Operating Income | 36.73% | 19.68% | 62.39% | 3.24% | -51.97% |
| Income Before Tax | 34.28% | 22.47% | 38.08% | 70.32% | 53.30% |
| Income Tax Expenses | -- | -- | -- | -- | 100.00% |
| Earnings from Continuing Operations | 34.28% | 22.47% | 38.13% | 70.29% | 53.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.28% | 22.47% | 38.13% | 70.29% | 53.27% |
| EBIT | 36.73% | 19.68% | 62.39% | 3.24% | -51.97% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 91.07% | 87.99% | 82.77% | 90.75% | 85.34% |
| Normalized Basic EPS | 91.07% | 87.99% | 82.76% | 90.75% | 85.65% |
| EPS Diluted | 91.07% | 87.99% | 82.77% | 90.75% | 85.34% |
| Normalized Diluted EPS | 91.07% | 87.99% | 82.76% | 90.75% | 85.65% |
| Average Basic Shares Outstanding | 636.12% | 545.78% | 259.11% | 221.09% | 218.65% |
| Average Diluted Shares Outstanding | 636.12% | 545.78% | 259.11% | 221.09% | 218.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |